Lisata Therapeutics(LSTA) - 2020 Q1 - Earnings Call Presentation

| --- | --- | --- | |-------|-------|---------------------------------------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Dedicated to Developing Therapies | | | | that Reverse Ischemic Disease | | | | David J. Mazzo, PhD | | | | President and Chief Executive Officer | May 7, 2020 | Nasdaq: CLBS Forward-looking statement 2 This Investor Presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-lookin ...